Estimated Medicaid Spending on Original and Citrate-Free Adalimumab From 2014 Through 2021-Reference-Cited by-同舟云学术

Estimated Medicaid Spending on Original and Citrate-Free Adalimumab From 2014 Through 2021

Published:2023-03-01 Issue:3 Volume:183 Page:275
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Wang Junyi¹,Lee ChangWon C.¹,Kesselheim Aaron S.¹,Rome Benjamin N.¹

Affiliation:

1. Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

Abstract

This cross-sectional study assesses Medicaid spending associated with citrate-free vs original adalimumab.

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2801010/jamainternal_wang_2023_ld_220048_1677616728.67084.pdf

Reference6 articles.

1. Randomized crossover comparison of injection site pain with 40 mg/0.4 or 0.8 ml formulations of adalimumab in patients with rheumatoid arthritis.;Nash;Rheumatol Ther,2016

2. Will ending the Medicaid Drug Rebate cap lower drug prices?;Rome;JAMA Intern Med,2021

3. Medicaid expenditures and estimated rebates on line extension drugs, 2010-2018.;Hwang;J Gen Intern Med,2022

4. Congressional Budget Office. A comparison of brand-name drug prices among selected federal programs. February 18, 2021. Accessed November 2, 2022. https://www.cbo.gov/publication/56978

5. Brennan? Z. House committee uncovers how Humira’s price spiked by 470% as AbbVie execs cashed bonuses tied to the hikes. Endpoints News. May 18, 2021. Accessed September 15, 2022. https://endpts.com/house-committee-uncovers-how-humiras-price-spiked-by-470-as-abbvie-execs-cashed-bonuses-tied-to-the-hikes/

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of Immunosuppression Among US Adults;JAMA;2024-03-12

2. Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups;Arthritis & Rheumatology;2023-05-24